# Study to Determine the Effects of Human Growth Hormone and Pioglitazone in Overweight, Prediabetic Adults

> **NCT00352287** · PHASE4 · COMPLETED · sponsor: **Stanford University** · enrollment: 60 (—)

## Conditions studied

- Obesity
- Metabolic Syndrome
- Impaired Glucose Tolerance

## Interventions

- **DRUG:** Recombinant human growth hormone; pioglitazone

## Key facts

- **NCT ID:** NCT00352287
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-03
- **Primary completion:** —
- **Final completion:** 2005-04
- **Target enrollment:** 60 (—)
- **Last updated:** 2006-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00352287

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00352287, "Study to Determine the Effects of Human Growth Hormone and Pioglitazone in Overweight, Prediabetic Adults". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00352287. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*